newsfilter
← Latest News
Business Wire·

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International LLC ("CCI"), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Agreement (the